Journey Medical Corporation (DERM) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

Journey Medical Corporation (DERM) closed at USD 5.13 on 2026-10-15, a change of -35.5 % over the past year, with a market capitalization of USD 140.13M.

Journey Medical Corporation recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Journey Medical Corporation key figures

Previous close

USD 5.13 (2026-10-15)

1-year change

-35.5 %

Market cap

USD 140.13M

Enterprise value

USD 140.03M

P/E ratio (trailing)

-22.57

P/E ratio (forward)

-82.75

EPS (trailing)

-0.22

EPS (forward)

-0.06

PEG ratio

n/a

Price to book

4.28

Revenue growth

23.3 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

17.61

Employees

58

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Journey Medical Corporation

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Journey Medical Corporation and compare it with other stocks.